News

Is your EMS agency using a NEMSIS-3 compliant data system?

Are you interested in improving the performance of your system?

Then, you are invited to participate in EMS Compass performance measure testing.

The EMS Compass Initiative is proud to announce the release of candidate measures for public testing. After much deliberation and national collaboration through an NQF-modeled measure development process, we are asking EMS agencies to help us refine these candidate measures before they receive final approval. They’ve been through the “lab testing” phase, but now it’s time to put them to the test in the real world.

What’s in it for you? Monitoring your performance over time with EMS Compass measures enables you to improve patient care directly in your system. You’ll learn a lot about the measures and provide EMS Compass with feedback that will improve the measures before they are finalized. We urge you to participate in this important phase of the evolution of these measures.
 
Your vendor may have enabled you to “turn on” EMS Compass measures in your system with little effort on your behalf. If not, you may be able to program these measures into your system. After you’ve had a chance to implement the measures, please visit the EMS Compass website to submit your feedback.
 
An EMS Compass Vendor Readiness guide, the information needed for manual implementation in your electronic patient care or analytic software, and feedback forms are available at http://www.emscompass.org/ems-compass-measures/.
 
If your system is not EMS Compass ready, we encourage you to contact your software vendor to request they incorporate EMS Compass measures into their software.

Urgent Medical Device Recall Notification

LMA® MAD NasalIntranasal Mucosal Atomization Device

One of these devices was provided in each WVEMS drug box.
Teleflex Medical is recalling these products as they may not deliver a fully atomized plume of medication. Teleflex Medical has received complaints that the affected lots produced a straight stream instead of an atomized spray. The failure of the device to deliver an atomized plume may impair the effectiveness of the medication with which it is used. This can lead to serious injury or death in certain emergency situations, such as where the device is used in an off-label
manner for needle-free delivery of drugs for reversal of life threatening narcotic overdose, reversal of life threatening hypoglycemia, or treatment of epileptic seizures.

Hospital Pharmacies: Please remove these devices from all drug boxes in your stock, and from boxes as they rotate through your pharmacy. Please place a sticker on the exterior of those boxes as follows: “This box does not contain intranasal atomization device due to recall” Please retain the devices as you remove them from boxes, as WVEMS will pick them up for return to the distributor.

At this time, there is no replacement available. We will provide more information as it becomes available.

The affected lot numbers that were distributed in our region are:

160313

The lot number is located on the plastic package, below the top bar code. DO NOT USE any device with one of these lot numbers.

MAD

160400
160518
160602
160631
160701
160418

Starting in May 2016, the ratio expression format for drug concentrations will no longer be permitted. This new development will apply to epinephrine, isoproterenol and neostigmine. Unaffected by this are the lidocaine and epinephrine combination solutions for local anesthesia.

The new labeling for epinephrine will only be displayed as the mass concentration format used in virtually every other medication. For example, epinephrine 1:1000 will now be labeled as 1 mg/mL, and for the 1:10,000 as 0.1 mg/mL. It is hoped that this change will decrease medication errors in the field and in the hospital. pdf See the explanation HERE. (159 KB)

Page 1 of 2

Upcoming Events From Our Calendar

Back To Top